Passive EEG-Guided Neuromodulation in Chronic Migraine: Findings from a Prospective Feasibility Study with Three-Month Follow-Up Using the Neurogen Brain Balancing Migraine Protocol (NGBBMP)
Introduction: Chronic migraine is a highly disabling neurological condition characterized by recurrent attacks, sensory hypersensitivity, and substantial functional impairment. Many individuals experience incomplete relief from pharmacologic therapies and effort-dependent behavioral interventions. Neurogen Brain Balancing (NGBB) is a fully passive, EEG-guided neuromodulation approach utilizing ultra-low-intensity pulsed transcranial signaling designed to support network-level regulation. This prospective study evaluated feasibility, tolerability, and preliminary clinical response patterns associated with a brief NGBB protocol in treatment-experienced migraineurs. Methods: Twenty adults (19 female, 1 male; mean age 40.5 years) with a mean migraine history of approximately 14 years completed five standardized 30-minute NGBB sessions over four weeks. Outcomes included validated migraine disability and impact measures (MIDAS, HIT-6), pain intensity ratings, quality-of-life (QOL) interference scales, global effectiveness ratings, and qualitative reports. Participants were invited to complete a voluntary 90-day follow-up assessment. Analyses emphasized descriptive statistics, pre-/post-comparisons, effect size estimation, and exploratory follow-up distributions. Results: Baseline migraine burden was substantial (mean ≈ 13 migraine days/month; mean pain 7.85/10). Following treatment, participants demonstrated marked reductions in disability and headache impact. MIDAS scores declined from 77.7 (Severe Disability) to 16.5 (Moderate Disability), representing an approximate 79% reduction. HIT-6 scores decreased from 67.15 (“Very Severe Impact”) to 53.95 (“Some Impact”). Quality-of-life interference improved by approximately 49% across measured domains. Effect sizes were large across principal outcomes (MIDAS d = 4.61; HIT-6 d = 8.32; QOL d = 6.75). At voluntary 90-day follow-up (n = 9 respondents), the majority reported sustained reductions in migraine frequency (89%), intensity (78%), and painfulness (78%). Most respondents clustered within minimal headache burden ranges, and severe pain ratings were absent. No worsening symptom patterns or moderate/severe delayed adverse events were reported. Conclusions: In this feasibility study of individuals with long-standing, treatment-experienced migraine, a brief course of passive EEG-guided neuromodulation was associated with rapid, multidimensional reductions in disability and headache impact. Exploratory follow-up findings demonstrated a
References
[1]
Nitsche, M.A. and Paulus, W. (2000) Excitability Changes Induced in the Human Motor Cortex by Weak Transcranial Direct Current Stimulation. The Journal of Physiology, 527, 633-639. https://doi.org/10.1111/j.1469-7793.2000.t01-1-00633.x
[2]
Stagg, C.J. and Nitsche, M.A. (2011) Physiological Basis of Transcranial Direct Current Stimulation. The Neuroscientist, 17, 37-53. https://doi.org/10.1177/1073858410386614
[3]
Monai, H. and Hirase, H. (2018) Astrocytic Calcium Signaling Regulates Blood-Brain Barrier Function and Neuroinflammatory Responses. Neuron, 98, 1109-1124.e6.
[4]
Fröhlich, F., Sellers, K.K. and Cordle, A.L. (2015) Targeting the Neurophysiology of Cognitive Systems with Transcranial Alternating Current Stimulation. Nature Reviews Neuroscience, 16, 88-95.
[5]
Herrmann, C.S., Rach, S., Neuling, T. and Strüber, D. (2013) Transcranial Alternating Current Stimulation: A Review of the Underlying Mechanisms and Modulation of Cognitive Processes. Frontiers in Human Neuroscience, 7, Article 279. https://doi.org/10.3389/fnhum.2013.00279
[6]
Fritsch, B., Reis, J., Martinowich, K., Schambra, H.M., Ji, Y., Cohen, L.G., et al. (2010) Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning. Neuron, 66, 198-204. https://doi.org/10.1016/j.neuron.2010.03.035
[7]
Thayer, J.F. and Lane, R.D. (2009) Claude Bernard and the Heart-Brain Connection: Auto-Nomic Regulation, Stress, and Health. International Journal of Psychophysiology, 73, 180-186.
[8]
Clancy, J.A., Mary, D.A., Witte, K.K., Greenwood, J.P., Deuchars, S.A. and Deuchars, J. (2014) Non-Invasive Vagus Nerve Stimulation in Healthy Humans Reduces Sympathetic Nerve Activity. Brain Stimulation, 7, 871-877. https://doi.org/10.1016/j.brs.2014.07.031
[9]
GBD 2019 Diseases and Injuries Collaborators (2020) Global Burden of Migraine and Tension-Type Headache, 1990-2019. The Lancet Neurology, 19, 903-934.
[10]
Steiner, T.J., Stovner, L.J., Jensen, R., Uluduz, D. and Katsarava, Z. (2020) Migraine Remains Second among the World’s Causes of Disability, and First among Young Women: Findings from GBD2019. The Journal of Headache and Pain, 21, Article No. 137. https://doi.org/10.1186/s10194-020-01208-0
[11]
Lipton, R.B., Bigal, M.E., Diamond, M., Freitag, F., Reed, M.L. and Stewart, W.F. (2007) Migraine Prevalence, Disease Burden, and the Need for Preventive Therapy. Neurology, 68, 343-349. https://doi.org/10.1212/01.wnl.0000252808.97649.21
[12]
Stewart, W.F. (2003) Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce. JAMA, 290, 2443-2454. https://doi.org/10.1001/jama.290.18.2443
[13]
Blumenfeld, A., Varon, S., Wilcox, T., Buse, D., Kawata, A., Manack, A., et al. (2010) Disability, HRQoL and Resource Use among Chronic and Episodic Migraineurs: Results from the International Burden of Migraine Study (IBMS). Cephalalgia, 31, 301-315. https://doi.org/10.1177/0333102410381145
[14]
Munakata, J., Hazard, E., Serrano, D., et al. (2009) Economic Burden of Migraine in the United States. Headache, 49, 858-870.
[15]
Hepp, Z., Bloudek, L.M. and Varon, S.F. (2014) Systematic Review of Migraine Prophylaxis Adherence and Persistence. Journal of Managed Care Pharmacy, 20, 22-33. https://doi.org/10.18553/jmcp.2014.20.1.22
[16]
Silberstein, S.D., Holland, S., Freitag, F., Dodick, D.W., Argoff, C. and Ashman, E. (2012) Evidence-Based Guideline Update: Pharmacologic Treatment for Episodic Migraine Prevention in Adults. Neurology, 78, 1337-1345. https://doi.org/10.1212/wnl.0b013e3182535d20
[17]
Diener, H., Holle, D., Solbach, K. and Gaul, C. (2016) Medication-Overuse Headache: Risk Factors, Pathophysiology and Management. Nature Reviews Neurology, 12, 575-583. https://doi.org/10.1038/nrneurol.2016.124
[18]
Arns, M., Heinrich, H. and Strehl, U. (2014) Evaluation of Neurofeedback in ADHD: The Long and Winding Road. Biological Psychology, 95, 108-115. https://doi.org/10.1016/j.biopsycho.2013.11.013
[19]
Hammond, D.C. (2005) Neurofeedback Treatment of Migraine Headache: A Preliminary Study. Applied Psychophysiology and Biofeedback, 30, 117-125.
[20]
Schoenen, J., Vandersmissen, B., Jeangette, S., Herroelen, L., Vandenheede, M., Gérard, P., et al. (2013) Migraine Prevention with a Supraorbital Transcutaneous Stimulator. Neurology, 80, 697-704. https://doi.org/10.1212/wnl.0b013e3182825055
[21]
Kasian, S.J. and Turetzky, R. (2025) Neurogen Brain Balancing: A Novel Passive, Non-Invasive Neurobiomodulation Modality for Brain Health. Health, 17, 307-332. https://doi.org/10.4236/health.2025.174022
[22]
Hjermstad, M.J., Fayers, P.M., Haugen, D.F., Caraceni, A., Hanks, G.W., Loge, J.H., et al. (2011) Studies Comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for Assessment of Pain Intensity in Adults: A Systematic Literature Review. Journal of Pain and Symptom Management, 41, 1073-1093. https://doi.org/10.1016/j.jpainsymman.2010.08.016
[23]
Stewart, W., Lipton, R., Kolodner, K., Liberman, J. and Sawyer, J. (1999) Reliability of the Migraine Disability Assessment Score in a Population-Based Sample of Headache Sufferers. Cephalalgia, 19, 107-114. https://doi.org/10.1046/j.1468-2982.1999.019002107.x
[24]
Kosinski, M., Bayliss, M.S., Bjorner, J.B., Ware, J.E., Garber, W.H., Batenhorst, A., et al. (2003) A Six-Item Short-Form Survey for Measuring Headache Impact: The HIT-6™. Quality of Life Research, 12, 963-974. https://doi.org/10.1023/a:1026119331193
[25]
Braun, V. and Clarke, V. (2006) Using Thematic Analysis in Psychology. Qualitative Research in Psychology, 3, 77-101. https://doi.org/10.1191/1478088706qp063oa
[26]
Burstein, R., Noseda, R. and Borsook, D. (2019) Migraine: Multiple Processes, Complex Pathophysiology. Journal of Neuroscience, 39, 8139-8149.
[27]
Dodick, D.W. (2018) A Phase‐by‐Phase Review of Migraine Pathophysiology. Headache: The Journal of Head and Face Pain, 58, 4-16. https://doi.org/10.1111/head.13300
[28]
Aurora, S. and Wilkinson, F. (2007) The Brain Is Hyperexcitable in Migraine. Cephalalgia, 27, 1442-1453. https://doi.org/10.1111/j.1468-2982.2007.01502.x
[29]
Noseda, R. and Burstein, R. (2013) Migraine Pathophysiology: Anatomy of the Trigeminovascular Pathway and Associated Neurological Symptoms, Cortical Spreading Depression, Sensitization, and Modulation of Pain. Pain, 154, S44-S53. https://doi.org/10.1016/j.pain.2013.07.021
[30]
Schwedt, T.J. and Chong, C.D. (2015) Functional Imaging and Migraine: New Connections? Current Opinion in Neurology, 28, 265-270. https://doi.org/10.1097/wco.0000000000000194
[31]
Dayan, E., Censor, N., Buch, E.R., Sandrini, M. and Cohen, L.G. (2013) Noninvasive Brain Stimulation: From Physiology to Network Dynamics and Back. Nature Neuroscience, 16, 838-844. https://doi.org/10.1038/nn.3422
[32]
Coppola, G., Di Renzo, A. and Pierelli, F. (2020) Habituation and Sensitization in Primary Headaches. The Journal of Headache and Pain, 21, 108.
[33]
Kasian, S.J., Turetzky, R. and Wingate, D.S. (2024) Exploring the Eight-Circuit Model of Consciousness: A Pathway to Enhanced Mind-Body Health. Health, 16, 1289-1303. https://doi.org/10.4236/health.2024.1612089
[34]
Ong, W., Stohler, C.S. and Herr, D.R. (2018) Role of the Prefrontal Cortex in Pain Processing. Molecular Neurobiology, 56, 1137-1166. https://doi.org/10.1007/s12035-018-1130-9
[35]
Jiang, Y., Oathes, D., Hush, J., Darnall, B., Charvat, M., Mackey, S., et al. (2016) Perturbed Connectivity of the Amygdala and Its Subregions with the Central Executive and Default Mode Networks in Chronic Pain. Pain, 157, 1970-1978. https://doi.org/10.1097/j.pain.0000000000000606
[36]
Gupta, S., Mehrotra, S., Villalón, C.M., Perusquía, M., Saxena, P.R. and MaassenVanDenBrink, A. (2007) Potential Role of Female Sex Hormones in the Pathophysiology of Migraine. Pharmacology & Therapeutics, 113, 321-340. https://doi.org/10.1016/j.pharmthera.2006.08.009
[37]
Krause, D.N., Warfvinge, K., Haanes, K.A. and Edvinsson, L. (2021) Hormonal Influences in Migraine—Interactions of Oestrogen, Oxytocin and CGRP. Nature Reviews Neurology, 17, 621-633. https://doi.org/10.1038/s41582-021-00544-2
[38]
Davidson, R.J. and McEwen, B.S. (2012) Social Influences on Neuroplasticity: Stress and Interventions to Promote Well-Being. Nature Neuroscience, 15, 689-695. https://doi.org/10.1038/nn.3093
